Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States

被引:34
|
作者
Fejzo, Marlena S. [1 ,3 ]
MacGibbon, Kimber W. [2 ]
Mullin, Patrick M. [3 ]
机构
[1] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
[2] Hyperemesis Educ & Res Fdn, Damascus, OR USA
[3] Univ So Calif, Keck Sch Med, Dept Maternal Fetal Med, Los Angeles, CA 90033 USA
关键词
Ondansetron; Hyperemesis gravidarum; Pregnancy; Nausea; Birth defect; Morning sickness; Heart defect; Cleft; NAUSEA;
D O I
10.1016/j.reprotox.2016.04.027
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This is an analysis of fetal outcome in pregnancies exposed to ondansetron to treat Hyperemesis Gravidarum (HG). In this retrospective cohort study, U.S. data on outcome were collected on 1070 pregnancies exposed to ondansetron and compared to outcomes in two control groups: 771 pregnancies in women with a history of HG with no ondansetron exposure and 1555 pregnancies with neither a history of HG nor ondansetron exposure. Ventricular septal defects were reported in 2/952 of infants in the HG/Ondansetron-exposure group and 4/1286 in the No HG/No Ondansetron-exposure group. Cleft palate was reported in 1/952 live births in the HG/Ondansetron and 2/1286 in the No HG/No Ondansetron-exposure groups. Women with a history of HG who took ondansetron reported less miscarriages and terminations, and higher live birth rates. The overall results do not support evidence of teratogenicity of ondansetron. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:87 / 91
页数:5
相关论文
共 50 条
  • [31] Impact of human immunodeficiency virus, malaria, and tuberculosis on adverse pregnancy outcomes in the United States
    Homa K. Ahmadzia
    Najma Khorrami
    Jené A. Carter
    Juliana Stone
    Richard L. Amdur
    Journal of Perinatology, 2020, 40 : 240 - 247
  • [32] Risk factors associated with cesarean section and adverse fetal outcomes in intrahepatic cholestasis of pregnancy
    Kong, Chengcai
    Zhu, Zonghao
    Mei, Fenglin
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [33] Desloratadine Use During Pregnancy and Risk of Adverse Fetal Outcomes: A Nationwide Cohort Study
    Andersson, Niklas Worm
    Poulsen, Henrik Enghusen
    Andersen, Jon Traerup
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (05): : 1598 - 1605
  • [34] The impact of fetal sex on risk factors for gestational diabetes and related adverse pregnancy outcomes
    Giuseppe Seghieri
    Graziano Di Cianni
    Elisa Gualdani
    Alessandra De Bellis
    Flavia Franconi
    Paolo Francesconi
    Acta Diabetologica, 2022, 59 : 633 - 639
  • [35] Risk of Invasive Haemophilus influenzae Infection During Pregnancy and Association With Adverse Fetal Outcomes
    Collins, Sarah
    Ramsay, Mary
    Slack, Mary P. E.
    Campbell, Helen
    Flynn, Sally
    Litt, David
    Ladhani, Shamez N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (11): : 1125 - 1132
  • [36] Endometriosis and Risk of Adverse Pregnancy Outcomes
    Farland, Leslie V.
    Prescott, Jennifer
    Sasamoto, Naoko
    Tobias, Deirdre K.
    Gaskins, Audrey J.
    Stuart, Jennifer J.
    Carusi, Daniela A.
    Chavarro, Jorge E.
    Horne, Andrew W.
    Rich-Edwards, Janet W.
    Missmer, Stacey A.
    OBSTETRICS AND GYNECOLOGY, 2019, 134 (03): : 527 - 536
  • [37] The impact of fetal sex on risk factors for gestational diabetes and related adverse pregnancy outcomes
    Seghieri, Giuseppe
    Di Cianni, Graziano
    Gualdani, Elisa
    De Bellis, Alessandra
    Franconi, Flavia
    Francesconi, Paolo
    ACTA DIABETOLOGICA, 2022, 59 (05) : 633 - 639
  • [38] Sibling risk for adverse pregnancy outcomes
    Plunkett, Jevon
    Muglia, Louis
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) : S186 - S186
  • [39] Maternal and fetal outcomes of autoimmune hepatitis in pregnancy: A United States hospitalized patient study
    Li, Xi
    Zhang, Jing
    Malik, Sheza
    Jain, Aakriti
    Wang, Mingyuan
    Niu, Chengu
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2025, 49 (03)
  • [40] The association between maternal influenza vaccination during pregnancy and adverse birth outcomes in the United States: Pregnancy risk Assessment Monitoring System (PRAMS)
    Xie, Shuai
    Monteiro, Karine
    Gjelsvik, Annie
    VACCINE, 2023, 41 (13) : 2300 - 2306